New Key Statistics Module, Z-Score and F-Score
SZSE:300791 Key Ratios
Market Cap ¥ M | 6,418.10 |
Enterprise Value ¥ M | 7,414.23 |
P/E(ttm) | 17.70 |
PE Ratio without NRI | 17.78 |
Forward PE Ratio | 14.31 |
Price/Book | 2.65 |
Price/Sales | 1.34 |
Price/Free Cash Flow | 178.30 |
Price/Owner Earnings | 136.40 |
Payout Ratio % | 0.72 |
Revenue (TTM) ¥ M | 4,127.00 |
EPS (TTM) ¥ | 1.54 |
Beneish M-Score | -2.32 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 8.90 |
y-y EBITDA Growth Rate % | 2.80 |
EV-to-EBIT | 18.36 |
EV-to-EBITDA | 18.36 |
PEG | 2.00 |
Shares Outstanding M | 235.87 |
Net Margin (%) | 8.13 |
Operating Margin % | 11.29 |
Pre-tax Margin (%) | 7.72 |
Quick Ratio | 1.90 |
Current Ratio | 2.61 |
ROA % (ttm) | 6.54 |
ROE % (ttm) | 13.51 |
ROIC % (ttm) | 10.89 |
Dividend Yield % | 4.06 |
Altman Z-Score | 3.12 |
SZSE:300791 Number of Guru Trades
SZSE:300791 Volume of Guru Trades
Gurus Latest Trades with SZSE:300791
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300791 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sirio Pharma Co Ltd Insider Transactions
No Available Data